Search Results 291-300 of 17371 for alopecia
... alopecia - Patients who are receiving any other investigational agents - Patients with uncontrolled intercurrent illness - Patients who cannot discontinue ...
Patients must have recovered sufficiently from all acute adverse effects of prior therapies, excluding alopecia. Patients must have an ECOG performance ...
All prior treatment-related toxicities must be Common Terminology Criteria for Adverse Events (CTCAE) version (v) 4 grade =< 1 (except alopecia); certain ...
... alopecia or laboratory abnormalities otherwise meeting eligibility requirements * Received prior chemotherapeutic, investigational, or other therapies for ...
Lenalidomide is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome (MDS). Patients with MDS may have very ...
... alopecia), which have not shown improvement and are strictly considered to interfere with current study medication; Co-administration of anti-cancer ...
- All grades of alopecia are acceptable - Endocrine dysfunction on replacement therapy is acceptable - Severe or unstable medical condition, including ...
Learn about this rare but serious condition of the adrenal glands that's treated by replacing hormones the body needs.
... alopecia and peripheral neuropathy =< grade 1 - Adequate excision: surgical removal of all clinically evident disease in the breast and lymph nodes as ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.